Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David White

Showing results (261-270 of 290) with videos related to

Pageof 29
Sort By:
Journal of Autoimmunity|July 10, 2022
Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosusWangbin Ning, Da Cheng, Philip H Howe, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 13, 2019
Needs and preferences for psychological interventions of people with motor neuron diseaseKirsty R Weeks, Rebecca L Gould, Christopher Mcdermott, et al.
Plos One|June 3, 2011
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006Eduard J Beck, Sundhiya Mandalia, Gary Lo, et al.
Lancet (London, England)|June 15, 2024
Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 15, 2018
The Cognitive Ageing, Nutrition and Neurogenesis (CANN) trial: Design and progressMichael A Irvine, Andrew Scholey, Rebecca King, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 27, 2017
Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized TrialJennifer F Hoy, Birgit Grund, Mollie Roediger, et al.
Journal of Molecular and Cellular Cardiology|January 11, 2011
Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammationXiao-Ming Gao, Yang Liu, David White, et al.
BMJ (Clinical Research Ed.)|November 13, 2015
Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trialSimon Gilbody, Elizabeth Littlewood, Catherine Hewitt, et al.
Health and Social Care Delivery Research|April 5, 2025
Multiple Symptoms Study 3 - An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled TrialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Plos One|January 7, 2011
Rising population cost for treating people living with HIV in the UK, 1997-2013Sundhiya Mandalia, Roshni Mandalia, Gary Lo, et al.
Pageof 29

Showing results (261-270 of 290) with videos related to

Sort By:
Pageof 29
Journal of Autoimmunity|July 10, 2022
Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosusWangbin Ning, Da Cheng, Philip H Howe, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 13, 2019
Needs and preferences for psychological interventions of people with motor neuron diseaseKirsty R Weeks, Rebecca L Gould, Christopher Mcdermott, et al.
Plos One|June 3, 2011
Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006Eduard J Beck, Sundhiya Mandalia, Gary Lo, et al.
Lancet (London, England)|June 15, 2024
Effectiveness of a symptom-clinic intervention delivered by general practitioners with an extended role for people with multiple and persistent physical symptoms in England: the Multiple Symptoms Study 3 pragmatic, multicentre, parallel-group, individually randomised controlled trialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 15, 2018
The Cognitive Ageing, Nutrition and Neurogenesis (CANN) trial: Design and progressMichael A Irvine, Andrew Scholey, Rebecca King, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 27, 2017
Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized TrialJennifer F Hoy, Birgit Grund, Mollie Roediger, et al.
Journal of Molecular and Cellular Cardiology|January 11, 2011
Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammationXiao-Ming Gao, Yang Liu, David White, et al.
BMJ (Clinical Research Ed.)|November 13, 2015
Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trialSimon Gilbody, Elizabeth Littlewood, Catherine Hewitt, et al.
Health and Social Care Delivery Research|April 5, 2025
Multiple Symptoms Study 3 - An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled TrialChristopher Burton, Cara Mooney, Laura Sutton, et al.
Plos One|January 7, 2011
Rising population cost for treating people living with HIV in the UK, 1997-2013Sundhiya Mandalia, Roshni Mandalia, Gary Lo, et al.
Pageof 29